RNAGene Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 4

RNAGene General Information

Description

Developer of a biopharmaceutical company intended to treat incurable diseases that cannot be solved with existing technology and products. The company promotes human health by developing biopharmaceuticals and mRNA-based drugs, enabling doctors to cure the patient and provide a healthy life.

Contact Information

Website
www.rnagene.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 605, 7 Beopwon-ro 6-gil
  • Songpa-gu
  • Seoul, 05855
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Number 605, 7 Beopwon-ro 6-gil
  • Songpa-gu
  • Seoul, 05855
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RNAGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A2) 07-Oct-2024 $1.5M Completed Pre-Clinical Trials
1. Seed Round Completed Pre-Clinical Trials
To view RNAGene’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

RNAGene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RNAGene Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
AI Angel Club Angel Group Minority
Angel Lounge VC-Backed Company Minority
Laplace Partners Venture Capital Minority
Capstone Partners Korea Venture Capital Minority
To view RNAGene’s complete investors history, request access »

Ready to get started?

Request a free trial

RNAGene FAQs

  • When was RNAGene founded?

    RNAGene was founded in 2015.

  • Where is RNAGene headquartered?

    RNAGene is headquartered in Seoul, South Korea.

  • What is the size of RNAGene?

    RNAGene has 10 total employees.

  • What industry is RNAGene in?

    RNAGene’s primary industry is Drug Discovery.

  • Is RNAGene a private or public company?

    RNAGene is a Private company.

  • What is RNAGene’s current revenue?

    The current revenue for RNAGene is .

  • How much funding has RNAGene raised over time?

    RNAGene has raised $5.34M.

  • Who are RNAGene’s investors?

    AI Angel Club, Angel Lounge, Laplace Partners, and Capstone Partners Korea have invested in RNAGene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process